Phase I Dose Escalating Trial Evaluating the Combination of Gemcitabine and Trabectedin in Patients With Advanced and/or Metastatic Leiomyosarcoma or Liposarcoma.
Phase of Trial: Phase I
Latest Information Update: 15 Dec 2014
At a glance
- Drugs Gemcitabine (Primary) ; Trabectedin (Primary)
- Indications Leiomyosarcoma; Liposarcoma
- Focus Adverse reactions
- 29 Nov 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 02 Sep 2011 New trial record